 |
|
|
| |
Continued Improvement in Renal Laboratory Parameters in CHB Patients Treated With
Tenofovir Alafenamide Compared With Tenofovir Disoproxil Fumarate Over 96 Weeks
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Wan Long Chuang,1 Kosh Agarwal,2 Jae Seok Hwang,3 Florin Caruntu,4 Florence Wong,5 Hie Won Hann,6 John Flaherty,7 Audrey Lau,7 Anuj Gaggar,7 Vithika Suri,7 Shuyuan Mo,7 G. Mani Subramanian,7 Aric Josun Hui,8 Hiroshi Yatsuhashi,9 Young Suk Lim10
1Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan; 2King's College Hospital, London, UK; 3Keimyung University Dongsan Medical Center, Daegu, South Korea; 4The National Institute for Infectious Diseases "Prof Dr Matei Bals," Bucharest, Romania; 5University Health Network, Toronto, Ontario, Canada;
6Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, USA; 7Gilead Sciences, Inc., Foster City, California, USA; 8Alice Ho Miu Ling Nethersole Hospital, Hong Kong; 9National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan; 10Asan Medical Center, Seoul, South Korea
|
| |
|
|
|
|
|
